Hyperphosphatemia clinical trials

The registry lists 148 studies for Hyperphosphatemia across more than 10 countries. 10 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-03.

Studies

Recruiting first, then most recently updated. Showing 50 of 148 — search for more.

• Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil CapsuleRecruitingNCT062061351 country
• Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)RecruitingNCT03573089Not applicable9 countries
• Phosphate in Acute PancreatitisRecruitingNCT07681050Phase 21 country
• A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With HyperphosphatemiaRecruitingNCT06712654Phase 22 countries
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)RecruitingNCT042784042 countries
• A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and ChinaRecruitingNCT06933472Phase 32 countries
• Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with HyperphosphatemiaRecruitingNCT06664125Phase 21 country
• Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis PatientsEnrolling by invitationNCT06406140Phase 2/31 country
• Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea PatientsRecruitingNCT061869341 country
• Improving Phosphate Control in Children With CKDRecruitingNCT054399801 country
• Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney DiseaseSuspendedNCT04523727Phase 31 country
• A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and DyslipidaemiaCompletedNCT00542386Phase 38 countries
• A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With HyperphosphatemiaCompletedNCT00506441Phase 32 countries
• A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With HyperphosphatemiaCompletedNCT00416520Phase 311 countries
• Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With HyperphosphatemiaCompletedNCT00772382Phase 32 countries
• Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy SubjectsCompletedNCT01976572Phase 11 country
• A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With HyperphosphatemiaCompletedNCT00542815Phase 315 countries
• AP301 Efficacy and Safety in Chinese Dialysis Patients With HyperphosphatemiaCompletedNCT07030595Phase 31 country
• Phosphate Diet Strategies to Lower Blood Phosphate in Dialysis PatientsCompletedNCT07180069Not applicable1 country
• Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney DiseaseCompletedNCT05085275Phase 31 country
• A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on HemodialysisCompletedNCT05699239Phase 21 country
• Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in JapanCompletedNCT02510274Phase 11 country
• Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal DialysisCompletedNCT019032131 country
• Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis PatientsCompletedNCT05577507Phase 41 country
• Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on HemodialysisCompletedNCT05897502Not applicable1 country
• Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing HemodialysisCompletedNCT04456803Phase 31 country
• Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney DiseaseCompletedNCT04579315Not applicable1 country
• A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HDCompletedNCT03831607Phase 21 country
• Dose-finding Study of KHK7791 in Hyperphosphatemia PatientsCompletedNCT03864458Phase 21 country
• Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia PatientsCompletedNCT03864445Phase 21 country
• A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia PatientsCompletedNCT05764590Phase 21 country
• Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. ParicalcitolTerminatedNCT01725113Phase 41 country
• mHealth for Phosphorus Management in CKD.Active, not recruitingNCT05389826Not applicable1 country
• Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HemodialysisCompletedNCT04771780Phase 31 country
• A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on DialysisCompletedNCT03427125Phase 31 country
• A Study of Ferric Citrate to Improve Inflammation and Lipid LevelsTerminatedNCT02661295Phase 41 country
• Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of HyperphosphatemiaCompletedNCT04549597Phase 41 country
• A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HPCompletedNCT03988920Phase 41 country
• Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder TherapyCompletedNCT03824587Phase 2/31 country
• Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis ParticipantsCompletedNCT04922645Phase 41 country
• A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis PatientsCompletedNCT04551300Phase 21 country
• av Fistula Patency Loss as a Cause of Fistula Failure and HyperphosphatemiaStatus unknownNCT055691091 country
• Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis PatientsCompletedNCT04046263Phase 41 country
• Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In ChinaCompletedNCT03001011Phase 31 country
• Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum ElectrolytesCompletedNCT042563691 country
• Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis PatientsCompletedNCT03079869Phase 41 country
• Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal DialysisCompletedNCT04766385Phase 31 country
• Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on HemodialysisCompletedNCT04766398Phase 31 country
• Clinical Study of KHK7791 in Hyperphosphatemia Patients on HemodialysisCompletedNCT04767581Phase 31 country
• Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis PatientsCompletedNCT03861247Phase 31 country